Abstract
Lung resident memory (Trm) CD8 T cells induced by influenza A virus (IAV) are pivotal for providing heterosubtypic immunity, but are not maintained long term, causing gradual loss of protection. This contrasts sharply with long-term maintenance of Trm induced by localized infections of the skin and other tissues. Here we show that the decline in lung Trm is determined by an imbalance between apoptosis and lung recruitment and conversion to Trm of circulating memory cells. At the cellular level, circulating effector memory (Tem) rather than central memory (Tcm) cells are the precursors for conversion to lung Trm. Time-dependent changes in expression of genes critical for lymphocyte trafficking and Trm differentiation, in concert with enrichment of Tcm, diminish the capacity of circulating memory CD8 T cells to form Trm with time, explaining why IAV-induced Trm are not stably maintained. Importantly, systemic booster immunization, through increasing the number of circulating Tem cells, increases lung Trm, providing a potential new avenue for future IAV vaccines.
Introduction
Seasonal influenza vaccination can provide effective antibody-mediated protection when the main surface antigen (hemagglutinin, HA) in the vaccine, matches that year’s circulating influenza A virus (IAV) strains. However, mutations in the globular head region of HA can reduce the neutralizing capacity of vaccine-induced antibodies(1). In the absence of neutralizing antibodies, IAV-specific memory CD8 T cells, which are maintained systemically as well as in the lung(2) correlate with some degree of control of viral titers and reduction of disease symptoms in humans(3, 4). Mouse models suggest it is the lung resident memory (Trm) CD8 T cells that enable swift and robust protection against IAV infection(5–8). Thus, establishing a robust long-term Trm population should be an important goal for an IAV vaccine.
Nonetheless, major knowledge gaps remain concerning lung Trm generation, maintenance and effector function, especially compared to Trm found in other non-lymphoid tissues such as skin, intestine and female reproductive tract. Mouse studies suggest that lung Trm share common traits with Trm from other tissues, most notably the expression of the transmembrane C-type lectin CD69 and αE-integrin CD103(7, 9). However at the transcriptome level lung Trm cells are distinct from skin Trm or intestinal Trm (10), suggesting differential adaptation to specific microenvironments. One clear difference is that, compared to Trm populations in other tissues(11), lung Trm have a limited longevity (7), which strongly correlates with waning of subtype transcending heterosubtypic immunity to IAV (7). Therefore understanding the maintenance of lung Trm may provide information that can be used to extend the life span of this population, thus prolonging heterosubtypic immunity to IAV.
Results
Limited longevity of IAV-induced lung Trm
Local infections, such as herpes simplex (HSV) and vaccinia virus (Vac), have been used to study the formation and maintenance of Trm in the skin (12). Skin Trm have a distinct phenotype, co-expressing CD69 and CD103, molecules that have a functional role in retention in the tissues (10). Moreover, compared to non-Trm, skin Trm express low levels of a key transcription factor, Eomesodermin (Eomes) (13). Importantly, the population of skin Trm is stably maintained (11) independently from the circulating memory CD8 T cell pool (12). In contrast, IAV-specific Trm cells are lost from the lung with time(14).
To address this discrepancy under conditions of a fixed TCR response, a small number of naive Thy1.1 P14 transgenic CD8 T cells (specific for the GP33 epitope of LCMV) were transferred into naive Thy1.2 C57Bl/6 recipients followed by epicutaneous (EC) infection of the ear with Vac expressing the LCMV GP33 epitope (Vac-GP33) or intranasal (IN) infection with IAV (PR8-GP33). An intravascular (IV) stain with anti-CD45 antibody was applied prior to euthanasia, to distinguish P14 cells in the tissue (IV−) from those remaining in small capillary beds (IV+)(15, 16). In line with previous work (11), after an initial decline, the number of Vac-GP33-induced skin Trm (defined as CD69+CD103+ P14 cells) and the total number of IV− P14 stabilized out to 200 days post infection (Fig. 1a, b). We also confirmed that Vac-GP33-induced skin Trm display stable and low expression of Eomes (Fig. S1a, b).
Lung Trm however, exhibited a different pattern. After an initial drop, there was an additional ~10-fold reduction in numbers of IV− P14 cells from 50 to 200 days post infection (Fig. 1c, d). In contrast to the skin, the number of P14 Trm in the lung parenchyma declined ~500-fold over the same time period (Fig. 1c, d). Importantly, IAV-induced lung Trm exhibited the same stable and low Eomes expression as Vac-induced skin Trm (Fig. S1c, d). Thus, despite their transience, IAV-generated lung IV− CD69+CD103+ CD8 T cells represented bona fide Trm.
Waning of lung Trm was not limited to P14 TCR-tg cells or recombinant IAV since endogenous Trm specific for an influenza nucleoprotein-derived epitope (NP366) also underwent ~500-fold decrease over the course of 200 days post IN PR8 infection (Fig. 1e, f). Importantly, the dramatic decline of IAV-induced lung Trm was not virus strain dependent as NP366-specific lung Trm declined in a similar manner by day 125 after IN infection with X31 IAV (Fig. 1g). Moreover, the observation of limited lung Trm longevity extended to respiratory infections other than IAV. IN infection of P14 recipients with Vac-GP33 induced GP33- and endogenous Vac B8R-specific lung Trm responses, which declined in a similar fashion as IAV-induced lung Trm (Fig. S2a–d). Thus, the differences between lung and skin Trm are not explained by the use of different viruses for each organ.
Finally, we confirmed that waning of IAV-induced lung Trm correlated with loss of CD8 T cell-mediated heterosubtypic protection. Primary exposure to H3N2 X31 IAV induced protection against challenge with heterosubtypic H1N1 PR8 IAV performed 30 days post X31 infection, measured by reduction of lung PR8 virus titers (Fig. 1h). Depletion of CD8 T cells rendered X31 immunized mice incapable of controlling PR8 virus titers. Heterosubtypic protection was completely lost at 125 days post initial X31 infection, which correlated with substantial decline in lung Trm (Fig. 1g, h).
In summary, these data showed, in models of fixed TCR-specificity with P14 TCR-transgenic T cells, that skin and lung Trm populations exhibit differences in durability and confirmed the observation that IAV-specific Trm populations were not stable in the lung (14). In turn, the loss of Trm correlated with reduced CD8 T cell dependent control of heterosubtypic IAV challenge(14), emphasizing the importance of understanding why the numbers of lung Trm decreased over time.
Apoptosis rather than migration drives the loss of IAV-generated Trm from the lung
To assess the possibility that some Trm migrate out of the lung and to determine the persistence of lung Trm, we labeled lung-residing cells using an in vivo CFSE labeling approach (17, 18). Intranasal inoculation of CFSE into mice previously infected with PR8-GP33 labeled all P14 cells in the lung parenchyma, but led to negligible CFSE staining of P14 cells in the draining lymph nodes and the spleen (Fig. S3), allowing for specific fate tracking of lung Trm. In vivo CFSE labeling of lung IV− P14 generated by intraperitoneal (IP) infection with LCMV Armstrong, an approach that does not generate lung Trm (Fig. S4), showed loss of labeled cells within 24 hours (Figure 2a, b). In contrast, IV− P14 cells generated through IN PR8-GP33 infection persisted with a half-life of ~5 days (Figure 2a, b). Loss of CFSE did not result from proliferation, as no discernable BrdU incorporation was detected in the CFSElo cells during this time period (Fig. S5). To assess whether Trm are lost by migration, entrance of lung Trm to the afferent lymphatics was blocked using the S1PR1 agonist FTY720 (19). FTY720 treatment did not prevent the loss of CFSE+ P14 from the lung parenchyma (Figure 2c), strongly suggesting that migration to the afferent lymph was not the primary mode of loss of IAV-generated Trm.
Alternatively, impaired maintenance of lung Trm could result from an increased apoptosis. In support of this notion we observed a higher percentage of IAV-induced IV− lung memory P14 expressing active caspases 3/7 (Flica stain) relative to IV+ lung memory P14, suggesting elevated pro-apoptotic activity in tissue-embedded cells (Figure 2d). Increased apoptosis is not a general feature of Trm, as we observed no difference in Flica staining between skin IV− memory P14 cells and their IV+ (blood) counterparts (Figure 2d). Furthermore, IV− CD103+ P14 cells displayed higher caspase 3/7 activity than CD103− P14 cells (Fig. 2e). Additionally, protein expression of the anti-apoptotic molecule Bcl-2 was substantially reduced in IV− memory P14 cells relative to the IV+ cells in the lung or in blood (Figure 2f). Importantly, decreased Bcl-2 protein expression in IV− relative to IV+ memory P14 cells was also observed at day 90 post infection, suggesting that compromised survival may be a sustained characteristic of lung Trm (Fig. S6). In contrast, skin IV− and IV+ circulating memory P14 cells exhibited similar level of Bcl-2 expression at day 30 post infection (Figure 2f). Of note, within the IV− P14 population, CD103+ cells had substantially decreased Bcl-2 expression compared to IV+ P14, while CD103− P14 cells had similar Bcl-2 expression to IV+ cells (Fig. 2g). Finally, we assessed the maintenance of mitochondrial membrane potential (ΔΨ mito), to evaluate the proapoptotic state of memory CD8 T cells in the lung after IAV infection (Fig. 2h, i). In line with increased Flica staining and decreased Bcl-2 expression, a larger fraction of IV− P14 cells exhibited decreased ΔΨ mito fluorescence compared to IV+ P14 (Fig. 2h). Additionally, IV− CD103+ cells showed lower ΔΨ mito fluorescence compared to their IV− CD103− counterparts (Fig. 2i). Together, these data showed that lung Trm were prone to apoptosis, suggesting that cell death, rather than migration to draining lymph nodes was the reason for the limited longevity of this CD8 T cell population.
Continuous seeding of lung Trm by precursors in the circulation in antigen-independent fashion
Despite the increased signature of apoptosis in the Trm population (Fig. 2d–i) and a steady decline of CFSE labeled Trm P14 cells in the lung parenchyma (Figure 2b), the total number of Trm cells did not decrease over the six day CFSE-chase interval (Fig. S7). As depicted in Figure 3a, the emergence of CFSE−, CD69+ or CD103+ P14 over time compensated for the loss of CFSE labeled memory P14 from the lung Trm pool. As proliferation was eliminated as a cause of disappearance of CFSE+ memory P14 cells (Fig. S5), these data suggest de novo generation of lung Trm from a memory population outside of the lung parenchyma. Given previous reports showing continuous recruitment of circulating memory CD8 T cells into the lung even weeks after the clearance of the infection(20, 21), we hypothesized that lung Trm were continuously formed from circulating precursors. Systemic antibody mediated depletion has been routinely used to show that, in most tissues, Trm are maintained independently from the circulating memory population(22, 23). However, antibody depletion of the systemic memory CD8+ T cell population also depleted lung Trm (Fig. S8). As an alternative, we utilized a system where depletion is based on cellular interactions (22). Male and female P14 cells were transferred in a 1:1 ratio into female recipients, which were subsequently infected either IN with PR8-GP33 or EC with Vac-GP33 (Fig. 3b). Male P14 cells underwent initial expansion in numbers like female P14 cells but were rejected from the circulation after 2 weeks (Fig. 3c). As previously reported (22), male P14 in the skin were detectable for several weeks after they were systemically rejected (Figure 3d, e), indicating maintenance of skin Trm without input from circulating memory CD8 T cells. Male P14 were also detectable in the lung parenchyma for several weeks after systemic rejection (Figure 3d, e) suggesting that the parenchyma provides a niche that shields male P14 from deletion. However, the 1:1 ratio is not maintained long-term and male P14 are progressively lost from the lung parenchyma (Figure 3d, e). Although we cannot formally exclude the possibility that anti-male cytotoxic T lymphocytes (CTL) gradually killed male P14 cells, in conjunction with the observed apoptosis of lung Trm (Figure 2d–i), these data strongly suggested that lung Trm were not adequately maintained without input from the circulating memory CD8 T cell population, and that maintenance of the lung Trm pool required continuous recruitment of circulation-derived precursors. Consistent with this hypothesis, blocking the entrance of circulating memory P14 into the lung parenchyma by administration of pertussis toxin (Ptx) 3 weeks after infection significantly (p<0.05) reduced the number of Trm in the lung parenchyma one week later. In contrast, Ptx treatment did not affect the number of systemic memory P14 in the spleen (Figure 3f). These data are consistent with the requirement for a continuous influx of memory P14 cells from the circulation to maintain stable lung Trm numbers over the short-term period.
Continuous formation of lung Trm has been proposed (24, 25) and was thought to be driven by persisting IAV antigen. Antigen has been shown to persist for at least 2 months in the lung after IAV infection (25), making this an attractive explanation for the continuous formation, but also the eventual disappearance of lung Trm (7). To confirm continuous recruitment of circulating memory CD8 T cells to the lung and to assess whether persisting antigen drives conversion of recruited memory CD8 T cells to lung Trm we adoptively transferred spleen derived (CD69−CD103−) memory P14 cells that were generated by X31-GP33 infection into naive, PR8 (no antigen) or PR8-GP33 (antigen) infected mice (Figure 4a). Analysis of the lung 1 week after transfer revealed de novo generation of Trm in all groups of mice (Figure 4b). A substantially larger fraction of transferred P14 cells entered the lung parenchyma of PR8 and PR8-GP33 infected mice compared to naive mice (Figure 4c). This suggested that the lung environment still drives additional recruitment of P14 cells into the parenchyma weeks after IAV infection, but this process does not require cognate antigen. Additionally, conversion to a Trm phenotype was higher in PR8 and PR8-GP33 infected compared to naive mice, suggesting the post-IAV lung environment was permissible to de novo Trm generation weeks after infection (Figure 4d). However, no difference in P14 conversion to Trm was observed between PR8 and PR8-GP33 infected mice. Thus, the IAV-experienced lung contains cues other than antigen to drive formation of lung Trm from circulating precursors. Cytokines like TGF-β, IL-33 and TNF have been implicated in formation of Trm (10, 26) with IL-33 specially implicated in the function of lung resident innate lymphocyte cells (ILC) (27). As IAV infection increased lung of IL-33 (28) and TNF(29) (Fig. S9), we transferred memory P14 CD8 T cells derived from spleens of PR8-GP33 infected mice into naive recipient mice (Fig. 4e) that were treated or not with blocking (anti-IL-33R) or neutralizing antibodies (anti-TNF) prior to analyses on day 7 (Fig. 4e). Blocking the IL-33 receptor reduced the number IV− P14 in the lung parenchyma (Figure 4f, g), but did not affect conversion to a Trm phenotype (Figure 4f, h.). On the other hand, neutralization of TNF reduced both the accumulation (Figure 4f, g) of P14 cells in the lung parenchyma and acquisition of Trm phenotype (Figure 4f, h), suggesting a role for this cytokine in formation and maintenance of lung Trm.
Thus, our data show that the maintenance of IAV-induced lung Trm CD8 T cell population critically depended on the circulatory CD8 T cell memory pool. Continuous seeding of the lung Trm niche by circulating memory CD8 T cells appeared to be antigen-independent, and at least partially driven by local inflammatory cues (e.g. IL-33 and TNF).
IAV-induced circulating memory CD8 T cells lose the capacity to form Trm over time
The capacity of circulating memory CD8 T cells to replenish lung Trm contradicts the observation that Trm are lost approximately 6 months post infection. Therefore, we hypothesized that with time circulating IAV-specific memory CD8 T cells lose their intrinsic capacity to generate Trm. To probe this, we transferred memory P14 cells isolated from spleens of mice infected with PR8-GP33 for 20–30 days (early memory) or >100 days (late memory) into recipient mice infected with PR8 virus 21 days before (Figure 5a). Late memory P14 cells showed a dramatic decrease in accumulation in the lung parenchyma relative to early memory P14 (Figure 5b). Furthermore, late memory P14 displayed poor conversion to a Trm phenotype compared to early memory P14 (Figure 5c). These data suggest that circulating memory CD8 T cells intrinsically lose the capacity to form lung Trm over time, independent of the change in the local inflammatory cues.
To assess the molecular signatures which could potentially explain the difference between early and late circulating memory CD8 T cells in forming lung Trm, we performed genome-wide mRNA expression in early (20–30 day post infection) and late (>100 days post infection) spleen-derived memory P14 generated by IN PR8-GP33 infection. Many genes (2,657; based on ≥1.25-fold difference, p<0.05) were differentially expressed in late vs. early memory P14, with a similar number being up- (1,326) or down-regulated (1,331) (Fig. S10a). Of note, transcriptome analysis suggested differential expression of 3 transcription factors identified as master regulators of Trm formation: Eomes (1.68x upregulated in late vs. early memory P14), Prdm-1 (Blimp-1) (2.19x downregulated in late vs. early memory P14) and Hobit (1.21x downregulated in late vs. early memory P14) (13, 30). Real-Time quantitative PCR (Q-PCR) analysis performed on mRNA isolated from early and late IAV-induced memory P14 demonstrated increased Eomes (p<0.0001) and decreased Blimp-1 (p=0.021) and Hobit (p=0.0033) mRNA expression in late vs. early splenic memory P14 cells (Fig. 6a). Intracellular protein staining confirmed that a substantially higher percentage of late compared to early memory P14 cells upregulated Eomes (Fig. 6b). Combined, these data show that the transcription factor profile of late memory P14 cells is incompatible with acquisition of Trm phenotype.
Additionally, ingenuity pathway analyses (IPA) revealed substantial alterations in a Leukocyte Migration gene set between late and early memory P14, represented by 158 genes (p=5.48×10−25) (Table S1). Importantly, gene set enrichment analysis (GSEA) showed that leukocyte migration-associated genes were significantly negatively enriched (FDR<0.01; normalized enrichment score −1.45) in late memory P14 (Fig. S10b), suggesting some compromise in ability to migrate to tissues. To further refine our gene analysis and focus only on T lymphocyte migration, we performed a literature-based selection of genes from the leukocyte migration pathways based on: a) expression by T lymphocytes and b) associated with cell movement/migration/chemotaxis. This approach shortlisted 70 genes, that were further divided to specific categories, based on the function of their protein products (Table S2). Notably, expression of most of these genes (>75%) was down-regulated in late vs. early memory P14 (Fig. S10c). Combined, the gene expression signatures strongly suggested that, with time, memory CD8 T cells downregulate the complex functional network of molecules collectively controlling cell migration to peripheral tissues. In turn, the reduced capacity of late memory CD8 T cells to enter lung tissue likely contributed to the decline in the Trm population.
Our data showed that with time, IAV-induced circulating memory CD8 T cells lose the capacity to form de novo lung Trm. We propose that inefficient conversion to Trm, based on an unfavorable transcription factor landscape, together with the decreased recruitment to the lung tissue due to loss of migratory capacity in late circulating memory CD8 T cells underlies the waning of lung Trm.
Circulating effector memory CD8 T cells are precursors of IAV-induced lung Trm
Interestingly, analyses of the Leukocyte Migration genes revealed that two out of the relatively few mRNAs enriched in late memory P14 cells were those coding for CCR7 and CD62L (Fig. S10c), well known to be required for homing to secondary lymphoid tissue and as canonical markers of central memory (Tcm) CD8 T cells (31). Additionally, we observed that the vast majority (>85%) of PR8-GP33 induced circulating memory P14 cells upregulated CD62L by day 90 post-infection. However, the Trm population in the lung was composed of predominantly CD62L− cells (Fig. 7a). As Trm P14 had a surface phenotype like Tem (CD62L−), it was highly likely that they were recruited from the circulating Tem pool, although active downregulation of CD62L upon recruitment to the lung could not be ruled out. To discriminate between these possibilities, PR8-GP33 induced splenic memory Thy1.1 P14 cells were isolated on day 65 post-infection (when an optimal ratio of CD62L+ and CD62L− P14 was observed), separated into enriched CD62L+ and CD62L− subpopulations and transferred into mice infected IN with PR8 IAV 21 days earlier (Fig. 7b) and their capacity to convert into Trm was assessed 7 days later. Of note, the Trm master regulator, Eomes, was differentially expressed in the donor populations with CD62L+ P14 (blue) being Eomeshi, and CD62L− (red) expressing less Eomes (Figure. 7c). Importantly, the vast majority (89%) of P14 cells isolated from the lungs of CD62L+ recipients were CD62L+, while most (76%) of the P14 cells in the lungs of CD62L− recipients were CD62L− (Fig. 7d). This finding strongly suggested that down-regulation of CD62L after cell entry into the lung was unlikely to account for the observed enrichment of Tem-like cells (CD62L−) in the lung. Of note, while P14 cells recovered from the lungs of CD62L− recipients (red) were found in the blood (IV+) and parenchyma (IV−), almost all P14 cells in the lungs of CD62L+ recipients (blue) were IV+, with only ~1% of cells residing in the parenchyma (Fig. 7e). Importantly, a discernable fraction of IV− P14 (~10%) formed CD69+CD103+ lung Trm in the CD62L− recipients (Fig. 7f). In contrast, we did not detect any lung Trm P14 in CD62L+ recipients (Fig. 7f).
Thus, our results identified circulating Tem as the precursors for de novo formation of IAV-specific lung Trm. These data suggested the intriguing hypothesis that expansion of the circulating Tem population induced by IAV infection could increase numbers of lung Trm. To test this hypothesis, we exposed PR8-GP33 immune or naive P14 recipient mice to systemic infection with recombinant L. monocytogenes expressing GP33 (LM-GP33) or an unrelated epitope derived from the P. berghei TRAP protein (LM-TRAP) (32, 33) 45 days after the initial PR8-GP33 infection (Fig. 8a). Mice were sacrificed 30 days after the systemic boost (75 days after initial PR8-GP33 infection) and circulating and lung P14 were analyzed (Fig. 8a). As predicted, systemic boosting with LM-GP33 enhanced the fraction of circulating Tem P14 cells (~84% were CD62L−), in sharp contrast to all the other immunization groups where circulating Tcm P14 dominated the response (Fig. 8b, c). As depicted in Fig. 8d, the most dramatic result of systemic boosting with LM-GP33 was an ~120x increase in the frequency of lung P14 memory cells, relative to non-boosted or LM-TRAP infected controls. Of note, naive mice that received the systemic LM-GP33 boost generated a circulating memory P14 population but did not generate a detectable population of P14 lung Trm (Fig. 8d, e). Additionally, boosting IAV immune mice with LM-TRAP did not alter P14 lung Trm numbers. However, in support of our hypothesis, the large increase in circulating Tem in PR8-GP33 immune mice boosted with LM-GP33 was associated with an ~10-fold increase in lung P14 Trm at 30 days post boost (Fig. 8d, e). The increase in lung Trm did not result from marked increase in frequencies of CD69+CD103+ P14 cells in the lung IV− population, but rather from an increase in the total number of lung IV− P14 cells in the LM-GP33 boosted mice (Fig. 8d, e). Thus, systemic boosting of IAV-induced memory CD8 T cell responses substantially increased the frequency of circulating Tem cells, which in turn enhanced the seeding of IAV-experienced memory CD8 T cells in the lung. The sustained ability of the lung environment to convert Tem to Trm, in the context of a larger number of lung parenchymal Tem, resulted in the substantial increase in number of lung Trm.
Discussion
Here we show that the maintenance of lung Trm contrasts sharply to well-studied skin Trm population. In concordance with earlier reports (7) we find a gradual loss of lung Trm (defined as IV− CD69+CD103+ cells) with time after IAV infection and concurrent loss of CD8 T cell mediated control of heterosubtypic infection. We provide evidence that lung Trm display enhanced apoptotic properties (increased caspase 3/7 level, reduced Bcl-2 expression and decreased mitochondrial membrane potential) when compared to skin Trm. Thus, the reduced Bcl-2 expression and other features of apoptosis in lung Trm appear to result from the tissue environment itself. The lung environment starkly contrasts the skin, both in term of physiology as well as microbiome composition (34), making it rather challenging to identify the reason for the enhanced apoptosis in this tissue. For example, multiple studies have demonstrated a crucial role of TGF-β in formation, but also maintenance of tissue resident memory T cells (10, 13, 26, 35–37). Furthermore, it has been shown recently that integrins αvβ6 and αvβ8 produced by skin stromal cells contribute to successful maintenance of Trm in this organ by activating latent TGF-β (37). It is possible that such sources of TGF-β are absent or only partially effective in the lung, thus limiting TGF-β signaling and survival of cells residing in lung parenchyma.
Alternatively, possible long-term elevated levels of TGF-β in the lung might lead to suppression of T-bet (13, 38, 39), which in combination with low expression of Eomes could result in inefficient IL-15 signaling in lung Trm (40). As cytokines signaling through common γ chain receptors, (e.g. IL-15), decrease T cell apoptosis through induction of Bcl-2, TGF-β induced deficiencies in cytokine signaling could decrease anti-apoptotic Bcl-2 and enhance apoptosis (41, 42).
As a further support for apoptosis rather than migration from the lung as a driving force of Trm disappearance, we showed that blocking of S1P1 mediated migration did not prevent the loss of Trm from the lung parenchyma. However, we cannot completely rule out that Trm CD8 T cells are shed into the airways, contributing to the gradual loss of the population in the lung parenchyma. Recent finding showing that a network of macrophages prevents shedding of CD4 Trm cells from female reproductive tract into the lumen, in a non-S1PR1 but rather cytokine-mediated manner, makes shedding of lung Trm CD8 T cell into the airway another possible scenario (43). Further studies of the mechanisms underlying the transient nature of IAV-induced lung Trm will require detailed analyses of tissue architecture, physiology and microbiology, as they jointly participate in shaping lung-specific environmental cues important for Trm formation and survival.
Interestingly, unlike skin Trm, which are maintained without input from the circulating memory CD8 T cell pool, lung Trm are replenished from CD69−CD103− circulating memory CD8 T cells even in the absence of persisting antigen. These results are in concordance with earlier reports using parabiotic mice (25, 44) or adoptive transfers (5, 6) which show that memory CD8 T cells can migrate into the lung during the steady state and in the absence of antigen. However these earlier studies did not use an IV stain to distinguish CD8 T cells in the lung parenchyma from those in the lung vasculature and did not employ the markers to distinguish whether the lung CD8 T cells were transient effector memory subsets or became genuine Trm.
Together, apoptosis of lung Trm and their replenishment from the circulating memory populations does not explain the gradual loss of lung Trm and protection. However, our results showing that circulating memory CD8 T cells lose the capacity to form lung Trm with time resolves this issue, and supports a model where decreasing cellular input, in combination with the loss of existing populations through apoptosis underlies the relatively slow decline of Trm in the lungs. Mechanistically, we show that with time circulating memory CD8 T cells acquire a transcription factor profile that may not be permissible for conversion to Trm in the lung (upregulated Eomes, downregulated Blimp-1 and Hobit) (13, 30). Additionally, bioinformatic analyses emphasize a loss in general migratory capacity in memory CD8 T cell populations with time, which supports our observation that circulatory memory CD8 T cells eventually lose the capacity to populate lung parenchyma.
Finally, we identify the circulating Tem pool as the main source of precursors for lung Trm. These results suggest that the progressive shift of systemic memory CD8 T cells towards Tcm, and concurrent loss of Tem populations, underlies the slow decay of IAV-induced lung Trm. Consistent with this notion, we show that systemic booster vaccination, through expansion of the circulating Tem population, can increase the numbers of lung Trm CD8 T cells. Interestingly, despite the >100x increase in frequency of lung CD8 T cells numbers of Trm increased only ~10-fold, suggesting that optimization of the booster approach may be possible. For example, IN boosting with replication deficient viruses expressing IAV antigens or concurrent induction of mild inflammation in the lung during boosting may further enhance lung Trm. Additionally, further work is needed to determine the durability of the boosted lung Trm.
In conclusion, we identify several key features of IAV-induced lung Trm CD8 T cells that differentiate them from Trm populations in other microenvironments. Additionally, we provide an explanation for the gradual decline of this population in the lung with time. Properties of IAV-induced lung Trm CD8 T cells most relevant for their transient nature are increased susceptibility to apoptosis and close dependence on circulating Tem pool for their maintenance. Importantly, expansion of the Tem population leads to an increase in numbers of lung Trm CD8 T cells, which may inform novel strategies to enhance the longevity of Trm pool and immunity to IAV infection.
Materials and methods
Study Design
The main aim of the study was to explain the gradual waning of IAV-induced lung Trm, which correlates with loss of heterosubtypic protection. For this purpose we adopted a mouse model of IAV infection. The initial phase of the study confirmed the appropriateness of our model and developed approaches to evaluate the biological status and longevity of IAV-induced lung Trm. Subsequent studies addressed the biology underlying recruitment and conversion of circulating memory CD8 T cells into lung Trm, the waning of this ability with time and the capacity of systemic booster immunization to restore lung Trm. All experiments were performed at least twice. The study involved sublethal infections with IAV or Vac or euthanasia prior to excessive body weight loss after IAV challenge, thus, no predetermined outcomes such as weight loss were used in the study and no outliers were excluded from the data analyses.
Mice
C57Bl/6 mice were originally derived from the National Cancer Institute (Fredericksburg, MD) and a colony is maintained in house. P14 transgenic mice (on a C57Bl/6 background) were acquired from Jackson Laboratories (Bar Harbor, ME). All animal studies and procedures were approved by the University of Iowa Animal Care and Use Committee, under PHS assurance, Office of Laboratory Animal Welfare guidelines.
Viral and bacterial infections
Influenza A/PR/08/34 H1N1 (PR8) and recombinant PR8 or X31 expressing GP33 (45, 46) were grown in chicken eggs. Allantoic fluid was diluted in PBS and mice received a sub-lethal dose (2×104 TCID50) while lightly anesthetized. Epicutaneous infection with Vaccinia virus expressing GP33 (Vac-GP33, a generous gift by Dr. Wherry at U Penn) was performed by applying 5×106 PFU of the virus on the center of the ear pinna, followed by poking 25 times with 27-gauge needle. For intranasal infection with Vac-GP33 mice were inoculated with 107 PFU of the virus. LCMV Armstrong infections were performed by intraperitoneal (IP) injection of 2×105 PFU of the virus. Systemic booster/mock booster immunizations were performed by IV injection of 107 CFU of recombinant L. monocytogenes expressing GP33 (LM-GP33) or a P. berghei TRAP-derived epitope (LM-TRAP (32).
Influenza protection and lung virus titers
C57Bl/6 mice were infected with X31 IAV (a reassortant IAV with 6 internal genes of PR8 and the hemagglutinin and neuraminidase of H3N2 A/Aichi/2/68). Heterosubtypic protection by early memory CD8 T cells was assessed 30 days post infection. Half of the mice were inoculated with CD8-depletion antibody, clone 2.43 (400 μg IP and 100 μg IN), while the rest of the animals were treated with equal amounts of Rat IgG control antibody. Two days post depletion, X31-immune mice and naive control animals were IN challenged with heterosubtypic PR8 (H1N1) virus. Lungs were harvested and virus titers assessed three days post challenge. Protection by late memory CD8 T cells was assessed in the same way, with PR8 challenge performed >100 days post initial X31 infection.
Intravascular staining and tissue preparation
Mice were intravenously injected with 2μg anti-CD45.2-APC (clone 104, Biolegend) in PBS. After 3 minutes mice were euthanized and whole lung or skin (ear) were isolated. Lung and skin were cut into small pieces and incubated 1 hour in a mixture of collagenase (125 U/ml) and DNAse (0.1 mg/ml) at 37°C. Single cell suspensions were obtained by forcing the organs through a 70 μm mesh screen. Erythrocytes were lyzed using Vitalyze (BioE, St. Paul, MN) and leukocytes were purified with 35% Percoll (GE Healthcare) in HBSS.
Statistical analysis
Comparison between 2 study groups was statistically evaluated by unpaired t-test, while comparisons between more than 2 groups were evaluated using multiple comparisons one- or two-way ANOVA, as specified in figure legends.
Supplementary Material
Acknowledgments
The authors wish to thank members of the Harty lab for insightful discussion and E. John Wherry (University of Pennsylvania) for the recombinant vaccinia virus.
Funding:
This work was supported by NIH grants AI 42767 and AI 114543 (JTH).
Footnotes
Author contributions:
BS, NVBB, GA, SSA, JTY designed experiments. BS and NVBB performed experiments and data analysis. GA performed IN Vac infection experiments and data analysis. SV provided crucial experimental reagents. BS, NVBB, GA, SSA, SMV and JTH contributed to writing and editing of the manuscript.
Competing interests:
The authors declare no competing interests
Data and materials availability: The following link has been created to allow review of record GSE86973 while it remains in private status: http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?token=ononsyewvfchnct&acc=GSE86973
References and notes
- 1.Epstein SL, Price GE. Cross-protective immunity to influenza A viruses. Expert Rev Vaccines. 2010;9:1325–1341. doi: 10.1586/erv.10.123. [DOI] [PubMed] [Google Scholar]
- 2.Piet B, et al. CD8(+) T cells with an intraepithelial phenotype upregulate cytotoxic function upon influenza infection in human lung. J Clin Invest. 2011;121:2254–2263. doi: 10.1172/JCI44675. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.McMichael AJ, Gotch FM, Noble GR, Beare PA. Cytotoxic T-cell immunity to influenza. The New England journal of medicine. 1983;309:13–17. doi: 10.1056/NEJM198307073090103. [DOI] [PubMed] [Google Scholar]
- 4.Sridhar S, et al. Cellular immune correlates of protection against symptomatic pandemic influenza. Nat Med. 2013;19:1305–1312. doi: 10.1038/nm.3350. [DOI] [PubMed] [Google Scholar]
- 5.Hogan RJ, et al. Activated antigen-specific CD8+ T cells persist in the lungs following recovery from respiratory virus infections. J Immunol. 2001;166:1813–1822. doi: 10.4049/jimmunol.166.3.1813. [DOI] [PubMed] [Google Scholar]
- 6.Slütter B, Pewe LL, Kaech SM, Harty JT. Lung airway-surveilling CXCR3(hi) memory CD8(+) T cells are critical for protection against influenza A virus. Immunity. 2013;39:939–948. doi: 10.1016/j.immuni.2013.09.013. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Wu T, et al. Lung-resident memory CD8 T cells (TRM) are indispensable for optimal cross-protection against pulmonary virus infection. J Leukoc Biol. 2013 doi: 10.1189/jlb.0313180. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.McMaster SR, Wilson JJ, Wang H, Kohlmeier JE. Airway-Resident Memory CD8 T Cells Provide Antigen-Specific Protection against Respiratory Virus Challenge through Rapid IFN-gamma Production. J Immunol. 2015;195:203–209. doi: 10.4049/jimmunol.1402975. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Wakim LM, Gupta N, Mintern JD, Villadangos JA. Enhanced survival of lung tissue-resident memory CD8(+) T cells during infection with influenza virus due to selective expression of IFITM3. Nat Immunol. 2013;14:238–245. doi: 10.1038/ni.2525. [DOI] [PubMed] [Google Scholar]
- 10.Mackay LK, et al. The developmental pathway for CD103(+)CD8+ tissue-resident memory T cells of skin. Nature immunology. 2013;14:1294–1301. doi: 10.1038/ni.2744. [DOI] [PubMed] [Google Scholar]
- 11.Mackay LK, et al. Long-lived epithelial immunity by tissue-resident memory T (TRM) cells in the absence of persisting local antigen presentation. Proc Natl Acad Sci U S A. 2012;109:7037–7042. doi: 10.1073/pnas.1202288109. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Gebhardt T, et al. Memory T cells in nonlymphoid tissue that provide enhanced local immunity during infection with herpes simplex virus. Nat Immunol. 2009;10:524–530. doi: 10.1038/ni.1718. [DOI] [PubMed] [Google Scholar]
- 13.Mackay LK, et al. T-box Transcription Factors Combine with the Cytokines TGF-beta and IL-15 to Control Tissue-Resident Memory T Cell Fate. Immunity. 2015;43:1101–1111. doi: 10.1016/j.immuni.2015.11.008. [DOI] [PubMed] [Google Scholar]
- 14.Wu T, et al. Lung-resident memory CD8 T cells (TRM) are indispensable for optimal cross-protection against pulmonary virus infection. J Leukoc Biol. 2014;95:215–224. doi: 10.1189/jlb.0313180. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Galkina E, et al. Preferential migration of effector CD8+ T cells into the interstitium of the normal lung. J Clin Invest. 2005;115:3473–3483. doi: 10.1172/JCI24482. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Teijaro JR, et al. Cutting edge: Tissue-retentive lung memory CD4 T cells mediate optimal protection to respiratory virus infection. J Immunol. 2011;187:5510–5514. doi: 10.4049/jimmunol.1102243. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Legge KL, Braciale TJ. Accelerated migration of respiratory dendritic cells to the regional lymph nodes is limited to the early phase of pulmonary infection. Immunity. 2003;18:265–277. doi: 10.1016/s1074-7613(03)00023-2. [DOI] [PubMed] [Google Scholar]
- 18.McGill J, Legge KL. Cutting edge: contribution of lung-resident T cell proliferation to the overall magnitude of the antigen-specific CD8 T cell response in the lungs following murine influenza virus infection. J Immunol. 2009;183:4177–4181. doi: 10.4049/jimmunol.0901109. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Ledgerwood LG, et al. The sphingosine 1-phosphate receptor 1 causes tissue retention by inhibiting the entry of peripheral tissue T lymphocytes into afferent lymphatics. Nature Immunology. 2008;9:42–53. doi: 10.1038/ni1534. [DOI] [PubMed] [Google Scholar]
- 20.Hogan RJ, et al. Long-term maintenance of virus-specific effector memory CD8+ T cells in the lung airways depends on proliferation. J Immunol. 2002;169:4976–4981. doi: 10.4049/jimmunol.169.9.4976. [DOI] [PubMed] [Google Scholar]
- 21.Kohlmeier JE, Miller SC, Woodland DL. Cutting edge: Antigen is not required for the activation and maintenance of virus-specific memory CD8+ T cells in the lung airways. J Immunol. 2007;178:4721–4725. doi: 10.4049/jimmunol.178.8.4721. [DOI] [PubMed] [Google Scholar]
- 22.Gebhardt T, et al. Different patterns of peripheral migration by memory CD4+ and CD8+ T cells. Nature. 2011;477:216–219. doi: 10.1038/nature10339. [DOI] [PubMed] [Google Scholar]
- 23.Schenkel JM, Fraser KA, Vezys V, Masopust D. Sensing and alarm function of resident memory CD8(+) T cells. Nat Immunol. 2013;14:509–513. doi: 10.1038/ni.2568. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Lee YT, et al. Environmental and antigen receptor-derived signals support sustained surveillance of the lungs by pathogen-specific cytotoxic T lymphocytes. Journal of virology. 2011;85:4085–4094. doi: 10.1128/JVI.02493-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Zammit DJ, Turner DL, Klonowski KD, Lefrancois L, Cauley LS. Residual antigen presentation after influenza virus infection affects CD8 T cell activation and migration. Immunity. 2006;24:439–449. doi: 10.1016/j.immuni.2006.01.015. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Skon CN, et al. Transcriptional downregulation of S1pr1 is required for the establishment of resident memory CD8+ T cells. Nat Immunol. 2013;14:1285–1293. doi: 10.1038/ni.2745. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Monticelli LA, et al. Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus. Nature immunology. 2011;12:1045–1054. doi: 10.1031/ni.2131. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Le Goffic R, et al. Infection with influenza virus induces IL-33 in murine lungs. Am J Respir Cell Mol Biol. 2011;45:1125–1132. doi: 10.1165/rcmb.2010-0516OC. [DOI] [PubMed] [Google Scholar]
- 29.DeBerge MP, Ely KH, Enelow RI. Soluble, but not transmembrane, TNF-alpha is required during influenza infection to limit the magnitude of immune responses and the extent of immunopathology. Journal of immunology. 2014;192:5839–5851. doi: 10.4049/jimmunol.1302729. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Mackay LK, et al. Hobit and Blimp1 instruct a universal transcriptional program of tissue residency in lymphocytes. Science. 2016;352:459–463. doi: 10.1126/science.aad2035. [DOI] [PubMed] [Google Scholar]
- 31.Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature. 1999;401:708–712. doi: 10.1038/44385. [DOI] [PubMed] [Google Scholar]
- 32.Doll KL, Pewe LL, Kurup SP, Harty JT. Discriminating Protective from Nonprotective Plasmodium-Specific CD8+ T Cell Responses. J Immunol. 2016;196:4253–4262. doi: 10.4049/jimmunol.1600155. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Sultan AA, et al. TRAP is necessary for gliding motility and infectivity of plasmodium sporozoites. Cell. 1997;90:511–522. doi: 10.1016/s0092-8674(00)80511-5. [DOI] [PubMed] [Google Scholar]
- 34.Yu G, et al. Characterizing human lung tissue microbiota and its relationship to epidemiological and clinical features. Genome Biol. 2016;17:163. doi: 10.1186/s13059-016-1021-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Sheridan BS, et al. Oral infection drives a distinct population of intestinal resident memory CD8(+) T cells with enhanced protective function. Immunity. 2014;40:747–757. doi: 10.1016/j.immuni.2014.03.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Zhang N, Bevan MJ. Transforming growth factor-beta signaling controls the formation and maintenance of gut-resident memory T cells by regulating migration and retention. Immunity. 2013;39:687–696. doi: 10.1016/j.immuni.2013.08.019. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Mohammed J, et al. Stromal cells control the epithelial residence of DCs and memory T cells by regulated activation of TGF-beta. Nat Immunol. 2016;17:414–421. doi: 10.1038/ni.3396. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Li MO, Sanjabi S, Flavell RA. Transforming growth factor-beta controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and -independent mechanisms. Immunity. 2006;25:455–471. doi: 10.1016/j.immuni.2006.07.011. [DOI] [PubMed] [Google Scholar]
- 39.Laidlaw BJ, et al. CD4+ T cell help guides formation of CD103+ lung-resident memory CD8+ T cells during influenza viral infection. Immunity. 2014;41:633–645. doi: 10.1016/j.immuni.2014.09.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Intlekofer AM, et al. Effector and memory CD8+ T cell fate coupled by T-bet and eomesodermin. Nat Immunol. 2005;6:1236–1244. doi: 10.1038/ni1268. [DOI] [PubMed] [Google Scholar]
- 41.Berard M, Brandt K, Bulfone-Paus S, Tough DF. IL-15 promotes the survival of naive and memory phenotype CD8+ T cells. J Immunol. 2003;170:5018–5026. doi: 10.4049/jimmunol.170.10.5018. [DOI] [PubMed] [Google Scholar]
- 42.Akbar AN, et al. Interleukin-2 receptor common gamma-chain signaling cytokines regulate activated T cell apoptosis in response to growth factor withdrawal: selective induction of anti-apoptotic (bcl-2, bcl-xL) but not pro-apoptotic (bax, bcl-xS) gene expression. Eur J Immunol. 1996;26:294–299. doi: 10.1002/eji.1830260204. [DOI] [PubMed] [Google Scholar]
- 43.Iijima N, Iwasaki A. T cell memory. A local macrophage chemokine network sustains protective tissue-resident memory CD4 T cells. Science. 2014;346:93–98. doi: 10.1126/science.1257530. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Klonowski KD, et al. Dynamics of blood-borne CD8 memory T cell migration in vivo. Immunity. 2004;20:551–562. doi: 10.1016/s1074-7613(04)00103-7. [DOI] [PubMed] [Google Scholar]
- 45.Mueller SN, et al. Qualitatively different memory CD8+ T cells are generated after lymphocytic choriomeningitis virus and influenza virus infections. J Immunol. 2010;185:2182–2190. doi: 10.4049/jimmunol.1001142. [DOI] [PubMed] [Google Scholar]
- 46.Decman V, et al. Cell-intrinsic defects in the proliferative response of antiviral memory CD8 T cells in aged mice upon secondary infection. J Immunol. 2010;184:5151–5159. doi: 10.4049/jimmunol.0902063. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.